Ambu AS (AMBU B):企業の財務・戦略的SWOT分析

◆英語タイトル:Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1094
◆発行会社(調査会社):GlobalData
◆発行日:2020年2月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Ambu AS (AMBU B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ambu A/S (Ambu) is a medical device company that manufactures and markets life supporting devices. It focuses on single-use devices for anesthesia, patient monitoring and diagnostics and emergency care. It serves hospitals, clinics, sleep laboratories and rescue services. The company’s product portfolio includes ventilation products for artificial respiration, resuscitators, single-use videoscopes, electrodes for ECG tests and neurophysiological tests, and manikins for first aid training. Ambu sells its medical devices through direct sales force and a network of distributors to hospitals and ambulances worldwide and operates offices in North America, Europe and Asia-Pacific. It has production facilities in China, Malaysia and the US. Ambu is headquartered in Ballerup, Denmark.

Ambu AS Key Recent Developments

Feb 04,2020: Ambu A/S: Interim report for Q1 2019/20
Nov 13,2019: Ambu: Changes within the board of directors
Nov 13,2019: Ambu: Annual report 2018/19
Aug 22,2019: Ambu: Interim report for Q3 2018/19
Jun 17,2019: Ambu: Review of the big five 2020 strategy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Ambu A/S – Key Facts
Ambu A/S – Key Employees
Ambu A/S – Major Products and Services
Ambu A/S – History
Ambu A/S – Company Statement
Ambu A/S – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Ambu A/S – Business Description
Business Segment: Anaesthesia
Overview
Performance
Business Segment: Patient Monitoring & Diagnostics
Overview
Performance
Business Segment: Visualisation
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of the world
Performance
Ambu A/S – Corporate Strategy
Ambu A/S – SWOT Analysis
SWOT Analysis – Overview
Ambu A/S – Strengths
Ambu A/S – Weaknesses
Ambu A/S – Opportunities
Ambu A/S – Threats
Ambu A/S – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Ambu A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Ambu A/S, Medical Equipment, Deals By Type, 2014 to YTD 2020
Ambu A/S, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 04, 2020: Ambu A/S: Interim report for Q1 2019/20
Nov 13, 2019: Ambu: Changes within the board of directors
Nov 13, 2019: Ambu: Annual report 2018/19
Aug 22, 2019: Ambu: Interim report for Q3 2018/19
Jun 17, 2019: Ambu: Review of the big five 2020 strategy
May 10, 2019: Ambu appoints new CEO
May 01, 2019: Ambu: Interim report for Q2 2018/19 and for the half-year
May 01, 2019: Ambu: Interim report for Q2 2018/19 and for the period 1 October 2018 – 31 March 2019
Mar 18, 2019: New Study: Reusable bronchoscopes cost more than sterile single-use bronchoscopes
Feb 04, 2019: Ambu announced Board Change
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Ambu A/S, Key Facts
Ambu A/S, Key Employees
Ambu A/S, Major Products and Services
Ambu A/S, History
Ambu A/S, Subsidiaries
Ambu A/S, Key Competitors
Ambu A/S, Ratios based on current share price
Ambu A/S, Annual Ratios
Ambu A/S, Annual Ratios (Cont...1)
Ambu A/S, Annual Ratios (Cont...2)
Ambu A/S, Interim Ratios
Ambu A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Ambu A/S, Medical Equipment, Deals By Type, 2014 to YTD 2020
Ambu A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Ambu A/S, Performance Chart (2015 - 2019)
Ambu A/S, Ratio Charts
Ambu A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Ambu A/S, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Ambu AS (AMBU B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ProAxsis Ltd-医療機器分野:企業M&A・提携分析
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • PanOptica Inc-製薬・医療分野:企業M&A・提携分析
    Summary PanOptica Inc (PanOptica) is a biopharmaceutical company that develops new ocular therapies in the field of ophthalmology. The company concentrates on candidates that are at or near the investigational new drug application stage. It licenses and develops novel therapeutics that can improve e …
  • Cameron International Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Cameron International Corporation (Cameron), a subsidiary of Schlumberger Limited specializes in engineering, designing, and manufacturing flow and pressure control technologies for oil and gas industry. The company offers drilling systems, dryaccess deepwater production systems, safety syst …
  • Dyson Group Plc:企業の戦略的SWOT分析
    Dyson Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Dine Brands Global, Inc. (DIN):企業の財務・戦略的SWOT分析
    Dine Brands Global, Inc. (DIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • PledPharma AB (PLED):企業の財務・戦略的SWOT分析
    Summary PledPharma AB (PledPharma) is a pharmaceutical company that discovers, manufactures, and develops drugs that protect the body against oxidative stress. The company discovers and develops Aladote and PledOx drugs. PledOX drug is used to prevent chemotherapy-induced side effects for colorectal …
  • Trustees Australia Ltd:企業の戦略・SWOT・財務分析
    Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Semperit AG Holding (SEM):企業の財務・戦略的SWOT分析
    Summary Semperit AG Holding (Semperit) is a developer, manufacturer and marketer of rubber products for the medical and industrial sectors. The company’s products comprise surgical gloves, examination gloves and reusable protective gloves. It also offers hydraulic hoses, industrial hoses, rubber she …
  • Relief Therapeutics Holding AG (RLF):企業の財務・戦略的SWOT分析
    Summary Relief Therapeutics Holding AG (Relief Therapeutics) is a drug development company that offers clinical development of peptides and proteins of natural or engineered origin. The company’s pipeline drug candidates include aviptadil for the treatment of sarcoidosis and low dose interleukin-6 t …
  • Qatar Shipping Co:企業の戦略的SWOT分析
    Qatar Shipping Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • First Light Biosciences Inc:製品パイプライン分析
    Summary First Light Biosciences Inc (FLB) is a medical device company that develops and manufactures automated medical diagnostic products for detection of healthcare associated infections. The company’s product include multipath analyzer. Its multipath analyzer detects resistant and sensitive staph …
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), a subsidiary of Aarti Group of Industries is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and special …
  • Unified Grocers, Inc.:企業の戦略的SWOT分析
    Unified Grocers, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ArcelorMittal:企業の戦略・SWOT・財務情報
    ArcelorMittal - Strategy, SWOT and Corporate Finance Report Summary ArcelorMittal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sao Paulo Alpargatas S.A.:戦略・SWOT・企業財務分析
    Sao Paulo Alpargatas S.A. - Strategy, SWOT and Corporate Finance Report Summary Sao Paulo Alpargatas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • TOA Corporation:企業の戦略・SWOT・財務情報
    TOA Corporation - Strategy, SWOT and Corporate Finance Report Summary TOA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • MNRB Holdings Berhad:企業の戦略・SWOT・財務情報
    MNRB Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary MNRB Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Facebook, Inc.:企業のM&A・事業提携・投資動向
    Facebook, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Facebook, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • AlloSource:企業の戦略的SWOT分析
    AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆